ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Astrocytic FDX1 Contributes to Copper Dyshomeostasis-associated Synaptic Dysfunction in Depression and Is Modulated by Exercise.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Major depressive disorder (MDD) is increasingly linked to astrocyte dysfunction, yet how systemic metabolic disturbances contribute to glial alterations remains unclear. Disruption of trace metal homeostasis, particularly copper, has emerged as a potential contributor, but the underlying cellular mechanisms are poorly defined. Here, we integrate clinical data and mouse models to investigate the role of copper dyshomeostasis in depression. We show that copper levels are elevated in the systemic circulation of patients with MDD and in the prelimbic cortex (PrL) of stressed mice. In mice, copper accumulation is associated with increased astrocytic ferredoxin 1 (FDX1) expression, accompanied by reduced astrocyte number and structural complexity, impaired calcium signaling, and disrupted excitatory synaptic function. Astrocyte-specific manipulations, in vivo calcium imaging, and electrophysiological recordings demonstrate that astrocytic FDX1 mediates the effects of copper imbalance on neural circuit dysfunction. Notably, physical exercise restores copper homeostasis, normalizes astrocytic FDX1 expression, improves astrocyte-neuron coupling, and alleviates depressive-like behaviors. These findings identify an astrocyte-mediated mechanism through which systemic copper imbalance influences neural function and provide insight into how exercise may mitigate depression-related neural dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.